Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder:: A double-blind, placebo-controlled study

被引:137
|
作者
Alonso, P
Pujol, J
Cardoner, N
Benlloch, L
Deus, J
Menchón, JM
Capdevila, A
Vallejo, J
机构
[1] Magnet Resonance Ctr Pedralbes, Barcelona, Spain
[2] Bellvitge Univ Hosp, Dept Psychiat, Obsess Compuls Disorder Clin & Res Unit, Barcelona, Spain
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2001年 / 158卷 / 07期
关键词
D O I
10.1176/appi.ajp.158.7.1143
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The efficacy of repetitive transcranial magnetic stimulation (rTMS) of the right prefrontal cortex for patients with obsessive-compulsive disorder (OCD) was studied under double-blind, placebo-controlled conditions. Method: Patients were randomly assigned to 18 sessions of real (N = 10) or sham (N = 8) rTMS. Treatments lasted 20 minutes, and the frequency was 1 Hz for both conditions, but the intensity was 110% of motor threshold for real rTMS and 20% for the sham condition. Results: No significant changes in OCD were detected in either group after treatment. Two patients who received real rTMS, with checking compulsions; and one receiving sham treatment, with sexual/religious obsessions, were considered responders. Conclusions: Low-frequency rTMS of the right prefrontal cortex failed to produce significant improvement of OCD and was not significantly different from sham treatment. Further studies are indicated to assess the efficacy of rTMS in OCD and to clarify the optimal stimulation characteristics.
引用
收藏
页码:1143 / 1145
页数:3
相关论文
共 50 条
  • [21] Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients
    Kamijima, K
    Murasaki, M
    Asai, M
    Higuchi, T
    Nakajima, T
    Taga, C
    Matsunaga, H
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (04) : 427 - 433
  • [22] A DOUBLE-BLIND, PLACEBO CONTROLLED-STUDY OF TRAZODONE IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER
    PIGOTT, TA
    LHEUREUX, F
    RUBENSTEIN, CS
    BERNSTEIN, SE
    HILL, JL
    MURPHY, DL
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (03) : 156 - 162
  • [23] Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial
    Mowla, Arash
    Ghaedsharaf, Mehrnoosh
    CNS SPECTRUMS, 2020, 25 (04) : 552 - 556
  • [24] Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial
    Noorbala, AA
    Hosseini, SH
    Mohammadi, MR
    Akhondzadeh, S
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (02) : 155 - 159
  • [25] Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Afshar, Hamid
    Akuchekian, Shahla
    Mahaky, Behzad
    Zarean, Elham
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (10): : 976 - 981
  • [26] A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder
    Hollander, E
    Koran, LM
    Goodman, WK
    Greist, JH
    Ninan, PT
    Yang, HC
    Li, D
    Barbato, LM
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (06) : 640 - 647
  • [27] Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study
    Ghaleiha, Ali
    Entezari, Neda
    Modabbernia, Amirhossein
    Najand, Babak
    Askari, Neda
    Tabrizi, Mina
    Ashrafi, Mandana
    Hajiaghaee, Reza
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (02) : 175 - 180
  • [28] Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study
    Emamzadehfard, Sahra
    Kamaloo, Atefeh
    Paydary, Koosha
    Ahmadipour, Ahmad
    Zeinoddini, Arefeh
    Ghaleiha, Ali
    Mohammadinejad, Payam
    Zeinoddini, Atefeh
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2016, 70 (08) : 332 - 341
  • [29] Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: A double-blind, placebo-controlled study
    Kauffmann, CD
    Cheema, MA
    Miller, BE
    DEPRESSION AND ANXIETY, 2004, 19 (01) : 59 - 62
  • [30] Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: A preliminary investigation
    Sachdev, PS
    McBride, R
    Loo, CK
    Mitchell, PB
    Malhi, GS
    Croker, VM
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (12) : 981 - 984